Category Archives: People

“Marc Beer, the CEO of Renovia Leds in Raising of $42 Million For Supporting Women Health “

Marc Beer is the CEO, chairman, and co-founder of Renovia Inc. which was established in August 2016. The Company is involved in developing numerous diagnostic and relaxing products to treat pelvic base disorders like urinary incontinence which approximately affects 250 million women globally. Marc was a graduate of Miami University in Ohio. He happens to possess more than 25 years’ experience as a manager in the pharmaceutical, biotechnology, diagnostic and device industries. A good example is OvaScience Company where he worked as a strategic consultant. Despite being such a busy man, he always makes time for his wife and three children. Speaking of Renovia, They have a new product called Leva which was sanctioned in April the previous year. Marc says that he developed the idea of taking the initiative to look for a solution for pelvic floor disorder from a gynecologist called Dr. Ray Iglesias. Marc is also the founding chairman of the directors’ board, the compensation committee, chairman to the Good Start Genetics Compensation committee (GSGCC) plus a member of Minerva Neurosciences INC Audit committee –MNIAC and also a Business Advisory Council –BAC of Miami University.

 

The Longwood Fund, an investment firm dedicated to health care joined hands with Renovia to advance and test four more therapeutic and diagnostic products including a new cohort of the Leva device. Marc beer Renovia’s CEO commented that “combining our innovative and proprietary sensor technologies and form factors with a digital health platform will give our customers valuable data to inform new treatment options, drive greater knowledge and understanding of pelvic floor disorders and ultimately lower long-term healthcare costs. Recently, it raised $42 million to improve the health of Boston Women. The money will go to product development pipeline and future business launches. Funding in Renovia mostly occurred in its Series A whereby the technology was got from another company. The series B is where Longwood re-instated into Renovia which was led by Ascension Ventures of Missouri and perceptive advisors of New York. It is important to note that the pelvic training product is designed to help women in performing strengthening exercises which is essential. This project will surely save a lot of lives. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing

 

“Renova Incorporation Continues to Thrive Under the Leadership of Marc Beer “

Marc Beer is the co-founder and CEO of Renovia Incorporation. The MedTech company is based in Boston. Renovia Inc. specializes in developing diagnostic and therapeutic products for treating and managing pelvic floor disorders such as urinary incontinence. Their first product, Leva, was approved by the FDA in April 2018. Research shows that more than 250 million in the world are affected by pelvic floor disorders.

 

Recently, the company obtained $32 million in the Series B round plus $10 million in venture debt, totaling to $42 million. The company is set to continue creating more products for managing pelvic floor disorders. One of the companies that joined the Series B round includes the Longwood Fund, a firm that invests in healthcare companies. The Longwood Fund was also part of Series A funding. Other funders for the Series B include Ascension Ventures, Missouri and Perceptive Advisors, New York.

 

Renovia Inc. intends to use the funds to develop and test four more products for diagnosing and treating pelvic floor disorders. One of the four devices includes the second version of the Leva device. Marc Beer was pleased by the support the company received from its investors. In a statement, he thanked the healthcare investors who share the company’s vision of improving diagnostic and therapeutic methods for pelvic floor disorders.

 

Renovia Inc. aims to give better treatment options, impart knowledge of pelvic floor disorders, and ultimately provide affordable diagnostic and treatment options. Marc believes that the company can achieve its goals by combining the innovative and sensor technology with a digital platform that informs the clients of new treatment options.

Marc Beer has over two decades of experience in the development and commercialization of pharmaceuticals, biotechnology, diagnostics, and devices. He co-founded Renovia Inc. with Yolanda Lorie and Ramon Iglesias, MD in August 2016. The team successfully closed Series A funding with top healthcare investors.

 

Besides Renovia Inc., Marc has founded and co-founded other companies such as ViaCell, a biotech company that majored in collecting, preserving, and developing umbilical cord blood stem cells. Marc led the company from its inception to a robust organization. Under his leadership, ViaCell grew to an employee base of 300. The company went public and was later acquired by PerkinElmer.

 

While serving as the CEO of ViaCell, Mark Beer served at Erytech Pharma in the Board of Directors. Prior to founding ViaCell, Marc served at Genzyme, and he held various positions including the Vice President of Global Marketing where his roles included launching several products that address rare diseases.

 

Marc Beer also held various sales and marketing positions in the pharmaceutical and diagnostic sector of Abbott Laboratories. He also served on the BIO (Biotechnology Industry Association).

The incredible passion and prowess for Marc Beer in building companies are amazing. His go-getter attitude has enabled him to achieve so much in life. Learn more: https://www.crunchbase.com/person/marc-beer

 

Marc Beer Charitable Acts to the Health Industry

Marc Beer is a prominent philanthropist for the support and development he has imposed in various health-related sectors. He is always on the front line to ensure that all patients are treated with respect and dignity. For over 25 years Marc Beer has earned extensive experience in biotechnology, diagnostic and pharmaceutical industries. He has worked in various companies serving at the top positions. Some of the companies include Anderson Pharmaceuticals where he served as the CEO. Marc Beer has also worked at ViaCell company where he played a significant role in the establishment of the company. ViaCell is a biotechnology company that specializes in collecting multiple umbilical cords and their stem cells they also ensure they are well preserved. Having Studied a B.S at Miami University based in Ohio Marc Beer served at Genzyme company that has devoted all their resources to establish treatments for all diseases that are difficult to be treated and diagnosed. He earned extensive experience working in these companies; he was able to launch Renovia company with other partners.

 

Marc Beer is the current CEO of Renovia company as well as the Chairman for the board of directors in the same company. Besides working at Renovia, he is the chairman at both Minerva Neuroscience and Good Start Genetics. Marc Beer has set a legacy in all these companies as he is always devoted to accomplishing all the set goals. In Renovia Marc Beer contributed to the raising of $50.3 million to fund the three rounds. On 21st August 2018, Marc Beer also raised money for the series B round. They raised about $32.3 Million with top investors like Western Technology investments, perceptive advisors and Ascension ventures. Marc Beer has also resulted in the adoption of modern technologies including SSL, iPhone, Viewport Meta among others to ensure that the company runs as planned. Marc Beer works closely with Ramon Iglesias, William Dull, Jose Bohorquez, and Jessica McKinney to ensure the smooth running of the company projects.

 

Recently, Marc Beer raised about $42 million to fund the establishment of a women health center based in Boston. This medical center is aimed at coming up with therapeutic, diagnostic products to aid treatment of pelvic disorders that millions of women are suffering from across the globe. Pelvic disorders include urinary inconsistency which keeps many women in discomfort. The money raised by Marc Beer`s company led to the establishment of Leva device which has been approved by FDA to be fit for diagnosing pelvic disorders.

 

This fund also will lead to research and combining advanced technologies to ensure that they come up with more effective treatments. Renovia has aligned with the Longwood Fund thus leading to the establishment of Missouri Ascension ventures that is devoted to transforming women lives. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html

 

“Marc Beer Involvement in Boston Women’s Health “

The pharmaceutical industry has grown over the years with the help of technological advancements such as the use of Artificial intelligence. Renovia is a market leading pharmaceutical company founded by Marc Beer and his partners.

 

The company incorporates technology in its practice whereby it operates on a digital-based platform which allows for diagnosis and treatment. This unique business model has contributed to the growth of the entity since it disrupts the conservative models used in the health sector.

 

Leadership is an integral part of a business and dictates the success or failure of the operations. Marc Beer occupies a leadership position at Renovia and this contributes to the overall success. He is competent in his practice since has twenty-five years of experience in biotechnology, pharmaceuticals, and technology. His expertise has seen him become an award-winning entrepreneur. Furthermore, he participates in philanthropic activities during his extra time making him an admirable man.

 

The improvement of Women’s health has been an issue which has resulted in numerous discussions due to the low standards of health services offered. Marc Beer has thus been active in the provision of solutions in this sector. This is through raising $42M dollars to be injected into the Boston women health startup project.

 

Renovia aligns to the objectives of the startup project which places key focus on pelvic disorders. Based on the article, the number of women suffering from pelvic floor disorders has continued to be on the rise as treatment procedures prove to be ineffective.

 

The active involvement in this project depicts the philanthropic nature and influence that Merc Beer has in the health industry. Urinary incontinence has greatly affected women across the world and hence is an issue that requires to be addressed. The money raised was through the implementation of a strategic business model that involves the use of venture debt.

 

The funds will thus be used to further research into the possible treatment options and medicine. Marc Beer anticipates a positive outcome from this project due to the success rate of already tested medicine such as Leva which is signed under Renovia.

 

Boston women health startup is highly reliant on the development of four products whose probability of success is quite high. This, in Merc Beer opinion, will only be possible through partnerships with high profile investors who will ensure the completion of the research, development, testing and rolling out of the medicine. He further states the importance of integrity and incorporation of effective systems to ensure that there is no wastage.

 

It is evident that Merc Beer is a believer in the synergy between various entities and the move to raise money influences and attracts other participants such as the government and health sector to alleviate Pelvic disorder issues. The Boston women startup project will further increase levels of awareness on the existence of Renova and potentially increase the number of users on the digital platform. Learn more: https://renoviainc.com

“Marc Beer “

Marc Beer is of age 52 years and has played the role of chairmanship in various companies. He was the Chairman and the Chief Executive Officer at Aegerion Pharmaceuticals Inc. before setting up Renovia, Inc.

 

Marc is the founder of the Renovia together with his two colleagues, Ramon, and Yolanda in the year 2016. After the set-up of the company, they successfully closed the leading in the matters regarding the Series A financing with their capital funds that were ventured in the business.

 

Marc Beer presently made his donation worth $42M with the aim of funding the health of the women startup at Renovia Inc. The primary goal of the company was to set up the diagnostic machines that were to be used in the treatment of the pelvic disorders. The amount was then channeled to develop and test the products that were to be used in the company. Marc has the expertise of more than 25 years in the field of development of the biotechnology and pharmaceutical device that is to be used in the diagnostic industries.

 

In the year 2000, Marc was the CEO of the ViaCell. This is the company that has specialized on the matters of the collection, preservation and even the development of the umbilical cord of the blood stem cells. Through a period of seven years after the company was set into its operation, it has attracted the attention of many and its goals placed to flow along the right lane of expectation. Through the leadership that was established in position by Marc, the company grew rapidly, and the number of the employees also increased up to 300. The company, therefore, went public in the year 2005, and it was later acquired by Perkin Elmer in the year 2007. The dedication that marc set and the leadership skills that he incorporated into the company made the company propelled to the highest position.

 

The skills of Marc that he had while at the position of the CEO at ViaCell made him serve at the location of the board of directors at Erytech Pharma. There was a lot of positive decisions that he made as the leader of the board while serving in the position. There are also several positions that mark was held before the position of the CEO at the ViaCell. For instance, he was serving as the Vice President of the Global Marketing where he had a huge responsibility of commercial launch products. Additionally, Marc was the Founding Chairman of the Good Start Genetics’ committee.

 

Marc has focused mainly on bringing the absolute best to the community, and this is the reason why he donated $42M to the organization. The capital that was needed to accomplish the projects and Marc has played a better role. Learn more: https://www.linkedin.com/in/marcbeer

 

“Marc Beer for Women’s Health “

Marc Beer is a gentleman who co-founded a new startup company called Renovia Incorporated. He graduated from Miami University with a Bachelor’s degree. Renovia Inc. was founded back in August of 2016 with two other founders, being Ramon Iglesias, MD and Yolanda Lorié. The company was initiated after the first round of funding, Series A, has been completed with venture healthcare funds behind it. Beer is not just the co-founder, but CEO of this new company as well. Co-founder, Marc Beer, while helping with the new company also serves as a member of OvaScience (Nasdaq: OVAS). He provides OVaScience with strategic consulting. Marc Beer is also a member of a cancer foundation group know as Joe Andruzzi Cancer Foundation. Since the opening of Renovia Incorporated, Marc Beer already has planned several new products for a disorder called pelvic floor disorders. He’ll be moving along with each new product the company is planning on producing. With the funds the company has raised, the total comes out to be 42 million dollars altogether. Series B round once it closed, was funded for 32 million dollars. Then the company obtained funds of 10 million dollars in venture debt. These funds will help with Renovia production and research purposes. Though the CEO was asked questions about the pipelines through investments none were answered as of yet.

 

Renovia Inc., a Boston-based medical-tech, is getting ready to produce 4 different types of therapeutical and diagnostic products for the disorder. The first of many new products approved for Marc Beer’s company was Leva. The approval of the product was announced by the FDA around April of last year. Leva was approximated to help around 250 million women around the world. It was made possible by investors who sole focus is on healthcare and the health of the women. Investors, like The Longwood Fund, invested early on in Renovia beginnings. The group joined in the Series B round, along with observational advisors and ascension ventures from locations, like New York and Missouri. All the funding goes straight to products of the new company, to help with the disorders. Renovia already has four more developing products, these products will go through the tests, before being sent to help millions of women in need. With some tenacity, the new incorporation will be able to produce a new and better Leva product. With innovations from the company and help from the funds, the CEO is hoping that the new technology will inform ways to treat and test the disorder. Effectively, it should help lower the long-term cost that would follow treatment. Marc Beer hopes and aspirations are to better the lives of women everywhere. Learn more: https://people.equilar.com/bio/marc-beer-aegerion-pharmaceuticals-/salary/78453

 

“Graeme Holm Trains his Customers in the Management of their Income at the Infinity Group Australia. “

Graeme Holm stayed in the employment for more than two decades before he had the thought of establishing the Infinity Group Australia. There were a lot of reasons that made him start the organization, but the main one was the oppression in which he had observed the credit customers in the region undergoing under the hands of the financial lender. The financial institutions had become so inconsiderate for their customers that they offered them deals that were never intended to satisfy their needs. The deals that were provided by the financial institutions were made in a way that the primary interest was to make huge profits from the lending process instead of first considering what the clients needed. Graeme Holm watched this while he worked for a bank in Sidney and felt that he could not tolerate it anymore. He made some arrangement with his wife, Rebecca Walker and opened the Infinity Group Australia in 2013.

 

The establishment of the company marked the end of some challenges that were common among the everyday credit customers of Australia. For instance, whenever the customers took loans from these banks and financial lenders, there were very high chances of defaulting the loans as a result of the customers having difficulties in the repayment process. This was a challenge that the typical financial institutions never bothered to address, and so many customers fell victim of the situation. Graeme Holm took the initiative of understanding the reason behind this infamous trend so that he could rescue his customers from the nightmare.

 

After conducting a survey, Infinity Group Australia found that most of the loan defaulters got themselves into the situation as a result of insufficient knowledge about how they could repay the loan. Despite having sufficient income to cater to the repayment process, they found that their expenditure was higher than their income could accommodate. Another challenge that Graeme Holm and his organization found out was that the customers never understood the terms under which the lenders granted them the loans and mortgages. This would often lead to some discrepancies between the lenders and the borrowers, which resulted in some disputes between the two parties. Learn more: https://www.yourmortgage.com.au/mortgage-brokers/best-mortgage-brokers/mpaaustralia-top-100-brokers-2017/13-graeme-holm-infinity-group-finance/243102/

 

After the research, Holm decided that for the customers to feel the difference between the services of Infinity Group Australia and those of other institutions, he had to address the problems that these clients were facing in the other organizations so that he could have the edge in the market. He made it his responsibility to train the customers before they accessed loans or any other credit services from Infinity Group. Holm also taught the customers in budgeting and the appropriate ways of managing their income. As a result, the customers of Infinity Group Australia have managed to pay more debt than the customers of the ordinary financial institutions.

 

Marc Beers is Committed to Improving the Health of its Customers

Marc Beer, businessman and entrepreneur, OS the co-foumder of Renovia, Inc

, and currently the CEO ( Chief Executive Officer) and chairman of the company. The entity is a medical technology company based on Boston, Massachusetts that is developing diagnostic and therapeutic devices that are used to treat pelvic floor disorders such as urinary incontinence. The company recently completed a round of funding and closed that round with a total of $42 million. Of that, $10 million was from Venture capital and $32 million was from Series B funding. The first product Renovia developed was a product called Leva which received FDA (Food and Drug Administration) approval on April,of 2018.

 

An early investor in Renovia was the Longwood Fund, an investing firm that focuses on healthcare. The Series B funding round was led by Perceptive Advisors and Ascenion Ventures. The funds from the capital raising effort will support the development and testing of four additional diagnostic and therapeutic products. Included in the effort will be an enhancement of the Leva product. Renovia is excited to have the support of those interested on the investment of such healthcare aspects. The products will ultimately benefit millions of women who differ from pelvic floor disorders. The products will ultimately benefit the millipn S of women who suffer from pelvic floor disorders. The combination of state of the art technology and funding will allow customers access to data and information that will allow them to make better informed decisions and add to the quality of life of many. The overall upshot is to help lower the cost of certain aspects of healthcare for users.

 

Marc Beer had more than 25 years of experience in the development and commercial marketing of pharmaceuticals, biotechnology and medical devices. In April of 2000, Beets was the founder and CEO of a biotechnogy company that focused on the collection and preservation process of umbilical cord blood stem cells. During his tenure at ViaCell, his leadership brought the company from start-up to a wry robust commercial enterprise. The company grew from a handful of employees to more than 300 and in 2007 the company was acquired by PerkinElmer.

 

Mr. b.Beets also served as a board of director member of Erytech Pharma, which is a biopharmaceutical company. Early in his career, Beers handled employment opportunities and challenges with a company called Genzyme. He was the Vice President of Global Marketing and he was responsible for launching several products that addressed several rate doase issues globally. He also served on the Governing Board of the Biotechnology Industry Organization Emerging Companies, as well as the Commonwealth of Massachusetts of Mass Life Science Board.

 

Marc Beets earned a Bachelor of Science degree (BS) from Miami University. He is also a mbet of the Miami University Business Advisory Council and a former member of the Notre Dame Graduate Studies Research and Advisory Council. Learn more : https://renoviainc.com/leadership/

Infinity Group Australia Finds Huge Success In Australian Finance.

Navigating the murky waters of financial maneuvering can be difficult for even the most attuned investor. With that being said, Graeme Holm of Infinity Group Australia learned early on in his financial advising career that far fewer people were equipped to deal with financial maneuvering than he had anticipated. Working primarily in a banking environment, Holm’s career was primarily focused on helping people work with personal finances, real estate investments, and financial planning. over 17 years, Holm got to know the average Australian investor and it made him realize that people simply weren’t prepared for the financial decisions they had to make. This line of thought brought Holm to establish the Infinity Group Australia which was just recently rewarded with one of the highest honors in the financial world.

 

It was recently announced that Infinity Group Australia scored the 58th spot on the Australian Financial Review’s list of Most Innovative Companies in Australia and New Zealand. That number may not sound impressive until you realize that 1,000 companies were included on the list. Infinity Group Australia’s addition to the list was a huge boon to their company and an emblem of the progress that Holm and his team have made over the years. Landing on the list at all meant that Infinity Group Australia would be sent into the homes of more than 1.8 million readers throughout the industry. Holm was more than proud of being added to the list, he was fired up and passioned with the inclusion. Holm would go on to attend the honorary event, accepting the award, before taking time to detail just how hard his team has worked in order to make it all a reality.

 

Infinity Group Australia was founded by Holm after 17 years in a banking environment. After getting to know the average Australian investor, Holm knew that he could provide so much more than simple financial services. Instead, Holm wanted to create something of a ‘personal trainer’ environment in order to help coach Australians in their financial affairs. The work at Infinity Group Australia was far more satisfying for Gram than his prior career had been and the results were just proof in the pudding. Still, that didn’t mean that Gram was easing himself into an easy career path. In actuality, the contrary was true. Learn more: https://au.linkedin.com/in/graeme-holm-b99b94ab

 

For Gram, moving into running his own business after almost two decades in the banking industry meant that he had to adjust, big time. Gram says that most of his days start at around 5:30 AM with a quick bit of exercise and a mental warm up. His entire day is mapped out into 30-minute sections and his focus is almost unwavering. He’ll typically work until around 10:30 PM where he then makes his next day’s schedule before falling asleep. This kind of schedule is grueling and you have to love the work in order to keep up with it. It’s easy to see that Gram hasn’t been grinding for no reason and the results have been exceptional for families throughout Australia.

 

Marc D. Beer

Marc D. Beer is a biotechnology executive with more than 20 years of experience in the diagnostic and pharmaceutical industries. Mr. Beer was the Chief Executive Officer of Aegerion Pharmaceuticals which produced various types of medications to treat specific diseases and illnesses.

 

Earlier in his biotech career, Marc held managerial positions at the following firms:

 

* ViaCell – company that specialized in preserving the blood stem cells of the umbilical cord

 

* Genzyme (Abbott Laboratories) – company that helped to develop treatments for rare diseases that were once considered untreatable.

 

* OvaScience – company that specializes in new treatments for couples and women struggling with infertility. OvaScience is merging with Millendo Therapeutics

 

* ERYTech Pharma – biopharmaceutical company that develops therapies for certain cancer and rare genetic diseases

 

* TxCell – company that develops T-cell immunotherapy systems

 

Marc Beer believes in making life better for people. For this reason, he created “Renovia, Inc.,” a medical diagnostic and therapeutic company. Marc serves as its Chief Executive Officer at its headquarters in Boston. Renovia will conduct clinical trials, produce medical products and develop many commercial ventures.

 

Marc founded Renovia to also research treatments to address the pelvic floor disorder. A pelvic floor issue involves incontinence which widely affects women around the globe. The Boston financial community stepped up with Marc enabling him to raise $42.3 million in financing for Renovia, Inc.

 

The FDA has already approved a Renovia product to address this health problem, which is the Leva device. The FDA has also approved certain drugs like the HoFH – homozygous familial hypercholesterolemia which is a rare disease that keeps high cholesterol levels within the body.

 

The Leva device is manufactured to strengthen the pelvic floor in women. The device is very innovative because it contains a sensor system that allows users to see the position of their pelvic floor muscles and to monitor any movement that is exerted during exercises.

 

Marc Beer received his Bachelor of Science degree from Miami University in Oxford, Ohio. He is also very active on medical and research boards like Minerva Neurosciences of Waltham, MA, where he serves as Chairman. He is Chairman of the Board at Good Start Genetics, Inc. of San Francisco, CA.

 

Marc also sits on the Board of Directors at the Biotechnology Innovation Organization headquartered in Washington, DC. and the Joe Andruzzi Cancer Foundation of North Attleboro, MA. Marc D. Beer is also a board member at the University of Notre Dame and RenaMed Biologics, Inc. Learn more : https://www.slideshare.net/MarcBeer